Explore the benefits and challenges of long-acting injectables (LAIs) in managing schizophrenia for improved patient outcomes.
Melissa Malinoski, PA-C
Advertisement
Articles by Melissa Malinoski, PA-C
Advertisement
Latest Updated Articles
Advantages of LAIs Over Daily Oral MedicationsPublished: September 8th 2025 | Updated:
The Role of LAIs in Schizophrenia: Convenience, Adherence, and AccessPublished: August 29th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
4
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
5
